Rhinitis News and Research

RSS
Rhinitis, commonly known as a runny nose, is the medical term describing irritation and inflammation of some internal areas of the nose. The primary symptom of rhinitis is nasal dripping. It is caused by chronic or acute inflammation of the mucous membrane of the nose due to viruses, bacteria or irritants.
Children with existing food allergy at increased risk of developing asthma and rhinitis

Children with existing food allergy at increased risk of developing asthma and rhinitis

Seasonal allergies may alter the brain, study shows

Seasonal allergies may alter the brain, study shows

Genome-wide study sheds light on evolution of pollen allergens

Genome-wide study sheds light on evolution of pollen allergens

HDM SLIT tablet can reduce risk of moderate or severe asthma exacerbation

HDM SLIT tablet can reduce risk of moderate or severe asthma exacerbation

Researchers observe worrisome increase in anaphylaxis rate

Researchers observe worrisome increase in anaphylaxis rate

MicroRNAs circulating in blood could lead to first diagnostic test for asthma

MicroRNAs circulating in blood could lead to first diagnostic test for asthma

Data traffic may help people better cope with pollution

Data traffic may help people better cope with pollution

Study assesses health problems related to food hypersensitivity

Study assesses health problems related to food hypersensitivity

Study: Many school children avoid basic foods due to perceived hypersensitivity

Study: Many school children avoid basic foods due to perceived hypersensitivity

New clinical study reveals previously unknown risk factors linked to keratoconus

New clinical study reveals previously unknown risk factors linked to keratoconus

FDA-approved, once-daily 24-hour aspirin now available for prevention of stroke and acute cardiac events

FDA-approved, once-daily 24-hour aspirin now available for prevention of stroke and acute cardiac events

Nuvo Research announces topline results from WF10 Phase 2 trial for treatment of allergic rhinitis

Nuvo Research announces topline results from WF10 Phase 2 trial for treatment of allergic rhinitis

Egalet, Teva sign agreement to commercialize SPRIX Nasal Spray in Israel, Gaza and the West Bank

Egalet, Teva sign agreement to commercialize SPRIX Nasal Spray in Israel, Gaza and the West Bank

Kanuma approved as first treatment for patients with LAL deficiency

Kanuma approved as first treatment for patients with LAL deficiency

New Haven Pharmaceuticals' DURLAZA drug delivers sustained antiplatelet control for full 24 hours

New Haven Pharmaceuticals' DURLAZA drug delivers sustained antiplatelet control for full 24 hours

Breastfeeding may not protect against allergies

Breastfeeding may not protect against allergies

Many seasonal allergy sufferers take OTC products rather prescription medications

Many seasonal allergy sufferers take OTC products rather prescription medications

Air pollution from forest fires aggravates children’s respiratory health

Air pollution from forest fires aggravates children’s respiratory health

Egalet announces launch of OXAYDO (oxycodone HCI, USP) Tablets and IMPACT-Rx initiative

Egalet announces launch of OXAYDO (oxycodone HCI, USP) Tablets and IMPACT-Rx initiative

Egalet to present scientific data on SPRIX Nasal Spray at Painweek 2015

Egalet to present scientific data on SPRIX Nasal Spray at Painweek 2015